Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Kos to copromote two cardiovascular drugs with Knoll

June 16, 1999

Bisoprolol receives first European approval for chronic heart failure

June 15, 1999

Treatment with MMP inhibitor attenuates ischemic damage in infarcted mice

June 15, 1999

Final analysis of Lyon Diet Heart Study reported

June 15, 1999

Alpha1-adrenoceptor antagonists in early development at Ono

June 14, 1999

SmithKline Beecham presents new enzyme inhibitors useful for treating atherosclerosis

June 14, 1999

Neurohumoral factors as predictors of benefit from carvedilol in ischemic LVD

June 14, 1999

Nippon Kayaku launches new treatment for heart failure in Japan

June 11, 1999

Scios and Bayer end commercial alliance for Natrecor

June 11, 1999

Antiischemic phenoxypyridines designed at Taisho

June 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...